RICT 2020

56th International Conference on Medicinal Chemistry
56èmes Rencontres Internationales de Chimie Thérapeutique

 Bordeaux, France    July 1-3, 2020

Confirmed speakers

A Long Quest for DNA Methylation Inhibitors and their Use to Kill Resistant Malaria Parasites

Dr Paola ARIMONDO
INSTITUT PASTEUR - CNRS UMR3523, Paris, France
Read more

Multi-target-Directed Ligands to Combat Neurodegenerative Diseases: All-In-One and One-For-All

Prof. Maria Laura BOLOGNESI
UNIVERSITY OF BOLOGNA, Bologna, Italy
Read more

Daridorexant - A Dual Orexin Receptor Antagonist

Dr Christoph BOSS
IDORSIA PHARMACEUTICALS LTD, Allschwil, Switzerland
Read more

The Genetic Code in Two Dimensions

Prof. Thomas CARELL
LUDWIG-MAXIMILIANS-UNIVERSITY, Munich, Germany
Read more

Bioorthogonal Protein Activation in Living Systems

Prof. Peng CHEN
PEKING UNIVERSITY, Beijing, China
Read more

Nanomedicine for the Treatment of Cancer and Neurological Disorders

Prof. Patrick COUVREUR
UNIVERSITE PARIS-SACLAY, Paris, France
Read more

Recent Advances in Breast Cancer Treatment: Discovery of SAR439859, a Selective Estrogen Receptor Degrader for the Treatment of Estrogen-Receptor-Positive Breast Cancer.

Dr Youssef EL AHMAD
SANOFI, Vitry Sur Seine, France
Read more

Peptide-Derived Ligands with Tailored Flexibility and their Use for Intracellular Targets

Prof. Tom GROSSMANN
VU UNIVERSITY AMSTERDAM, Amsterdam, The Netherlands
Read more

Ligand-directed Labeling of Endogenous Proteins in Live Cells

Prof. Itaru HAMACHI
KYOTO UNIVERSITY, Japan

Expanding the Genetic Code - Chemistry in Living Systems

Prof. Kathrin LANG
TECHNICAL UNIVERSITY OF MUNICH, Garching, Germany

Biomimetic Chemistry of Human RNAi Therapeutics

Dr Mano MANOHARAN
ALNYLAM PHARMACEUTICALS, Cambridge, United States
Read more

Title to be announced

Dr Darryl MCCONNELL
BOEHRINGER INGELHEIM RCV, Vienna, Austria

Sulfatase Inhibitors: From Concept to Clinical Trials and Beyond

Prof. Barry POTTER
UNIVERSITY OF OXFORD, Oxford, United Kingdom
Read more

Targeting Protein-Protein Interactions in Receptor Complexes

Prof. Kristian STROMGAARD
UNIVERSITY OF COPENHAGEN, Copenhagen, Denmark
Read more

Identification of the Potent, Highly Selective and Orally Bioavailable ATR Inhibitor BAY 1895344

Dr Franz VON NUSSBAUM
BAYER AG, Berlin, Germany